Immunotherapies
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
6
NCT04271163
Transcranial Electromagnetic Treatment (TEMT) Against Alzheimer's Disease
Phase: Phase 1/2
Role: Collaborator
Start: Feb 10, 2020
Completion: Mar 31, 2021
Loading map...